Gene therapy of atherosclerosis

Area of Science:

• Cardiovascular Research
• Molecular Medicine
• Genetics

Background:

• Atherosclerosis is a primary cause of mortality globally, initiating early in life but manifesting clinically much later.
• Current therapeutic strategies for atherosclerosis are limited in addressing its multifactorial nature.
• Gene therapy presents a novel avenue for targeting the complex genetic and molecular underpinnings of atherosclerosis.

Purpose of the Study:

• To review current gene therapy strategies for atherosclerosis.
• To discuss potential vectors and gene targets for therapeutic intervention.
• To evaluate the preclinical and clinical evidence for gene therapy in cardiovascular diseases.

Main Methods:

• Review of preclinical studies (in vitro and in vivo) on gene therapy for atherosclerosis.
• Analysis of clinical trial data on gene therapy applications in cardiovascular diseases.
• Discussion of various gene therapy vectors and approaches.

Main Results:

• Numerous genes implicated in atherosclerosis development have been identified as potential therapeutic targets.
• Preclinical studies demonstrate the feasibility and safety of gene therapy for atherosclerosis.
• Clinical trials indicate the potential applicability of gene therapy for cardiovascular disease treatment.

Conclusions:

• Gene therapy holds significant promise for treating atherosclerosis by targeting multiple contributing factors.
• Further research and clinical trials are warranted to optimize gene therapy approaches for cardiovascular health.
• Gene therapy represents a potential paradigm shift in managing atherosclerosis and related conditions.